Company Filing History:
Years Active: 2001-2004
Title: Jane A Endicott: Innovator in Cancer Research
Introduction
Jane A Endicott is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of cancer research, particularly through her innovative work on cyclin-dependent kinase inhibitors. With a total of 2 patents, her inventions are paving the way for new therapeutic options in the treatment of tumors and other cell proliferation disorders.
Latest Patents
Endicott's latest patents include a range of pyrimidine derivatives that act as inhibitors of cyclin-dependent kinases (CDKs). These compounds provide useful therapeutic options for treating tumors and other disorders related to cell proliferation. The unique binding mechanism of these compounds to CDK molecules distinguishes them from known CDK inhibitors such as olomoucine and roscovitine. Additionally, she has developed purine derivatives that also inhibit CDK activity, offering further methods for treating tumors and cell proliferation disorders.
Career Highlights
Jane A Endicott is associated with Cancer Research Campaign Technology Limited, where she continues to advance her research and innovations. Her work has been instrumental in developing new pharmaceutical compositions that target cancer treatment effectively.
Collaborations
Throughout her career, Endicott has collaborated with notable colleagues, including Roger J Griffin and Alan H Calvert. These partnerships have enhanced her research and contributed to the success of her inventions.
Conclusion
Jane A Endicott's contributions to cancer research through her innovative patents highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapeutic options for cancer treatment.